For the analysis, researchers used data from the Medicare Plan Finder website last November and December to examine annual 2019 out-of-pocket costs for 30 specialty-tier drugs for cancer, hepatitis C, multiple sclerosis and rheumatoid arthritis. They looked at Medicare Part D plans that cover the drug, based on coverage in stand-alone prescription drug plans and costs at a pharmacy in ZIP code 21201 in Baltimore, Md.
That ZIP code approximates prescription drug plan costs nationally because 24 of the 25 Medicare Part D prescription drug plans in that ZIP code are offered nationally or near nationally. Researchers said prescription drug plans also typically use the same formulary and the same specialty-tier coinsurance rate nationally, making the analysis applicable to a majority of U.S. Medicare Part D prescription drug plan enrollees.
While researchers looked at 30 specialty-tier drugs, two of them, Gleevec and Viekira Pak, are not covered by any plan in 2019.
Here is the median annual out-of-pocket cost for the drugs, based on the foundation’s analysis:
Cancer
1. Zytiga – $8,181
2. Erleada – $8,586
3. Venclexta – $8,712
4. Nerlynx – $8,842
5. Imatinib mesylate – $8,983
6. Verzenio – $9,164
7. Calquence – $10,175
8. Rubraca – $10,386
9. Alunbrig – $11,014
10. Zejula – $11,625
11. Rydapt – $11,830
12. Kisqali – $12,145
13. Revlimid – $14,461
14. Idhifa – $16,551
15. Gleevec – N/A
Hepatitis C
16. Zepatier – $2,622
17. Harvoni – $6,338
18. Mavyret – $3,520
19. Epclusa – $5,283
20. Vosevi – $5,306
21. Sovaldi – $5,633
22. Viekira Pak – N/A
Rheumatoid arthritis or multiple sclerosis
23. Kevzara – $4,372
24. Orencia – $5,207
25. Enbrel – $5,465
26. Humira – $5,471
27. Avonex – $6,507
28. Tecfidera – $6,595
29. Copaxone – $6,672
30. Glatiramer acetate – $7,409
Access the full analysis findings here.
More articles on pharmacy:
Prescription drug price transparency and its visible impact on medication adherence
Key thoughts on controlling pharmacy spend for hospitals
CVS, Walgreens piloting dental services: 3 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
